Stay updated on Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, signaling a backend or template update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-30T15:25:00.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision tag was updated to version v3.6.5, reflecting a new release of the site template used for the study page.
    Difference
    0.0%
    Check dated 2026-08-09T09:18:14.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing v3.6.3. This reflects a small patch to the page's revision tag with no changes to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-25T17:56:52.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.6.3, replacing the previous Revision: v3.6.2, signaling a small update to the site template or interface rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T09:18:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.2, signaling a newer page version. This seems to be a small, non-content-related update to the page version.
    Difference
    0.0%
    Check dated 2026-06-27T06:40:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate that no further participant enrollment is being sought, and new help sections are added to guide users on reading the study record and how to join the study.
    Difference
    0.4%
    Check dated 2026-06-13T03:23:28.000Z thumbnail image

Stay in the know with updates to Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.